人类沃顿氏果冻和骨髓间充质干细胞的成软骨分化:无丙烯酰胺交联透明质酸水凝胶的作用

Letizia Pelusi, Valeria Schiavone, G. Bologna, Pietro Cerritelli, Deborah Lezza, A. Pantalone, Manuela Santalucia, R. Buda, A. Pandolfi, Domitilla Mandatori
{"title":"人类沃顿氏果冻和骨髓间充质干细胞的成软骨分化:无丙烯酰胺交联透明质酸水凝胶的作用","authors":"Letizia Pelusi, Valeria Schiavone, G. Bologna, Pietro Cerritelli, Deborah Lezza, A. Pantalone, Manuela Santalucia, R. Buda, A. Pandolfi, Domitilla Mandatori","doi":"10.29011/2575-8241.001209","DOIUrl":null,"url":null,"abstract":"Hyaluronic Acid (HA) is a natural biopolymer commonly used to reduce inflammatory process in degenerative joint disease such as Osteoarthritis (OA). In the last years, its possible use as biocompatible scaffold for cartilage tissue engineering was highlighted. In this field, to achieve promising results, recent studies have underlined the advantages of combining tissue engineering and cell therapy approaches. To date, the mainly cells employed for cartilage regeneration are Mesenchymal Stem Cells (MSCs) isolate from bone marrow. However, since their use has several limitations, there was a growing interesting in MSCs from perinatal tissue, such as umbilical cord, as possible source for cartilage regeneration. Therefore, the aim of this study was to investigate the role of an innovative acrylamide-free cross-linked HA Hydrogel formulation (HyLink®) on chondrogenic differentiation process employing both human umbilical cord Wharton’s jellyand Bone Marrow-derived MSC (hUC-WJ-MSC s and hBM-MSCs). Our data showed that the HyLink improved the chondrogenic differentiation in both mesenchymal cellular models as revealed by the increase of Glycosaminoglycans (GAGs) deposition and the mRNA levels of chondrogenic markers (SOX9, COL2a1 and ACAN). In addition, the results demonstrated that hUC-WJ-MSC have a greater cartilage differentiation potential compared to the MSCs isolated from bone marrow. Overall, our results demonstrate that HyLink improves chondrogenic differentiation process both in hBM-MSCs and hUC-WJ-MSC . Since the latest showed greater cartilage differentiation potential, we suggest that MSCs isolated from perinatal tissue might be a promising cell source for regenerative medicine in the orthopedic field. Citation: Pelusi L, Schiavone V, Bologna G, Cerritelli P, Lezza D, et al. (2021) Chondrogenic Differentiation of Human Wharton’s Jelly and Bone Marrow-Derived Mesenchymal Stem Cells: Focus on the Role of an Acrylamide-Free Cross-Linked Hyaluronic Acid Hydrogel. J Orthop Res Ther 6: 1209. DOI: 10.29011/2575-8241.001209 2 Volume 6; Issue 06 J Orthop Ther, an open access journal ISSN: 2575-8241","PeriodicalId":87310,"journal":{"name":"Journal of orthopedic research and therapy","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Chondrogenic Differentiation of Human Wharton’s Jelly and Bone Marrow-Derived Mesenchymal Stem Cells: Focus on the Role of an Acrylamide-Free Cross-Linked Hyaluronic Acid Hydrogel\",\"authors\":\"Letizia Pelusi, Valeria Schiavone, G. Bologna, Pietro Cerritelli, Deborah Lezza, A. Pantalone, Manuela Santalucia, R. Buda, A. Pandolfi, Domitilla Mandatori\",\"doi\":\"10.29011/2575-8241.001209\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hyaluronic Acid (HA) is a natural biopolymer commonly used to reduce inflammatory process in degenerative joint disease such as Osteoarthritis (OA). In the last years, its possible use as biocompatible scaffold for cartilage tissue engineering was highlighted. In this field, to achieve promising results, recent studies have underlined the advantages of combining tissue engineering and cell therapy approaches. To date, the mainly cells employed for cartilage regeneration are Mesenchymal Stem Cells (MSCs) isolate from bone marrow. However, since their use has several limitations, there was a growing interesting in MSCs from perinatal tissue, such as umbilical cord, as possible source for cartilage regeneration. Therefore, the aim of this study was to investigate the role of an innovative acrylamide-free cross-linked HA Hydrogel formulation (HyLink®) on chondrogenic differentiation process employing both human umbilical cord Wharton’s jellyand Bone Marrow-derived MSC (hUC-WJ-MSC s and hBM-MSCs). Our data showed that the HyLink improved the chondrogenic differentiation in both mesenchymal cellular models as revealed by the increase of Glycosaminoglycans (GAGs) deposition and the mRNA levels of chondrogenic markers (SOX9, COL2a1 and ACAN). In addition, the results demonstrated that hUC-WJ-MSC have a greater cartilage differentiation potential compared to the MSCs isolated from bone marrow. Overall, our results demonstrate that HyLink improves chondrogenic differentiation process both in hBM-MSCs and hUC-WJ-MSC . Since the latest showed greater cartilage differentiation potential, we suggest that MSCs isolated from perinatal tissue might be a promising cell source for regenerative medicine in the orthopedic field. Citation: Pelusi L, Schiavone V, Bologna G, Cerritelli P, Lezza D, et al. (2021) Chondrogenic Differentiation of Human Wharton’s Jelly and Bone Marrow-Derived Mesenchymal Stem Cells: Focus on the Role of an Acrylamide-Free Cross-Linked Hyaluronic Acid Hydrogel. J Orthop Res Ther 6: 1209. DOI: 10.29011/2575-8241.001209 2 Volume 6; Issue 06 J Orthop Ther, an open access journal ISSN: 2575-8241\",\"PeriodicalId\":87310,\"journal\":{\"name\":\"Journal of orthopedic research and therapy\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of orthopedic research and therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.29011/2575-8241.001209\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of orthopedic research and therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29011/2575-8241.001209","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

透明质酸(HA)是一种天然的生物聚合物,通常用于减少骨关节炎等退行性关节疾病的炎症过程。在过去的几年里,它作为软骨组织工程的生物相容性支架的可能用途被强调。在这个领域,为了取得有希望的结果,最近的研究强调了组织工程和细胞治疗方法相结合的优势。迄今为止,用于软骨再生的主要细胞是从骨髓分离的间充质干细胞(MSC)。然而,由于它们的使用有几个局限性,来自围产期组织(如脐带)的MSCs作为软骨再生的可能来源越来越令人感兴趣。因此,本研究的目的是研究一种创新的无丙烯酰胺交联HA水凝胶制剂(HyLink®)在软骨分化过程中的作用,该制剂同时使用人脐带Wharton凝胶和骨髓衍生MSC(hUC WJ MSC和hBM MSC)。我们的数据显示,HyLink改善了两种间充质细胞模型中的软骨分化,如糖胺聚糖(GAGs)沉积和软骨形成标记物(SOX9、COL2a1和ACAN)mRNA水平的增加所示。此外,结果表明,与从骨髓中分离的MSC相比,hUC WJ MSC具有更大的软骨分化潜力。总之,我们的结果表明,HyLink改善了hBM-MSC和hUC-WJ-MSC的软骨分化过程。由于最近的研究显示出更大的软骨分化潜力,我们认为从围产期组织中分离的MSCs可能是骨科领域再生医学的一个有前途的细胞来源。引文:Pelusi L、Schiavone V、Bologna G、Cerritelli P、Lezza D等人(2021)人类沃顿果冻和骨髓来源的间充质干细胞的软骨分化:关注无丙烯酰胺交联透明质酸水凝胶的作用。骨科研究杂志6:1209。DOI:10.29011/2575-8241001209 2第6卷;第06期骨科杂志,开放获取期刊ISSN:2575-8241
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Chondrogenic Differentiation of Human Wharton’s Jelly and Bone Marrow-Derived Mesenchymal Stem Cells: Focus on the Role of an Acrylamide-Free Cross-Linked Hyaluronic Acid Hydrogel
Hyaluronic Acid (HA) is a natural biopolymer commonly used to reduce inflammatory process in degenerative joint disease such as Osteoarthritis (OA). In the last years, its possible use as biocompatible scaffold for cartilage tissue engineering was highlighted. In this field, to achieve promising results, recent studies have underlined the advantages of combining tissue engineering and cell therapy approaches. To date, the mainly cells employed for cartilage regeneration are Mesenchymal Stem Cells (MSCs) isolate from bone marrow. However, since their use has several limitations, there was a growing interesting in MSCs from perinatal tissue, such as umbilical cord, as possible source for cartilage regeneration. Therefore, the aim of this study was to investigate the role of an innovative acrylamide-free cross-linked HA Hydrogel formulation (HyLink®) on chondrogenic differentiation process employing both human umbilical cord Wharton’s jellyand Bone Marrow-derived MSC (hUC-WJ-MSC s and hBM-MSCs). Our data showed that the HyLink improved the chondrogenic differentiation in both mesenchymal cellular models as revealed by the increase of Glycosaminoglycans (GAGs) deposition and the mRNA levels of chondrogenic markers (SOX9, COL2a1 and ACAN). In addition, the results demonstrated that hUC-WJ-MSC have a greater cartilage differentiation potential compared to the MSCs isolated from bone marrow. Overall, our results demonstrate that HyLink improves chondrogenic differentiation process both in hBM-MSCs and hUC-WJ-MSC . Since the latest showed greater cartilage differentiation potential, we suggest that MSCs isolated from perinatal tissue might be a promising cell source for regenerative medicine in the orthopedic field. Citation: Pelusi L, Schiavone V, Bologna G, Cerritelli P, Lezza D, et al. (2021) Chondrogenic Differentiation of Human Wharton’s Jelly and Bone Marrow-Derived Mesenchymal Stem Cells: Focus on the Role of an Acrylamide-Free Cross-Linked Hyaluronic Acid Hydrogel. J Orthop Res Ther 6: 1209. DOI: 10.29011/2575-8241.001209 2 Volume 6; Issue 06 J Orthop Ther, an open access journal ISSN: 2575-8241
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信